Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Journal of Reports in Pharmaceutical Sciences
  4. Articles

  5. Cannabinoids as Treatment for Hemophilic Arthropathy: Hypothesized Molecular Pathways
  6. Scopus by Title (Ref)

Journal of Reports in Pharmaceutical Sciences

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Publication Malpractice StatementReviewer and AE Registration FormSupportContact Us
APCAnnouncement of New Publisher
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Cannabidiol as a possible treatment for endometriosis through suppression of inflammation and angiogenesis

- Anvari Aliabad R. , et al.

2. Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story?

- Ashtar Nakhaei N. , et al.

3. Curcumin: hopeful treatment of hemophilic arthropathy via inhibition of inflammation and angiogenesis

- Norooznezhad F. , et al.

4. Missing angiogenic factors in hemophilic arthropathy

- Norooznezhad A.H. , et al.

5. Bevacizumab inhibits angiogenic cytokines in head and neck squamous cell carcinoma: From gene to the protein

- Heydar H. , et al.

HomeInstructionsAPCAnnouncement of New Publisher

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Publication Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.